Clarametyx Biosciences

Columbus, OH · Founded 2019 · Privately Held (backing)

Developer of immune-facilitated biologic therapies designed to fight life-threatening infections. Clarametyx Biosciences is based in Columbus, OH and was founded in 2019. It was valued at $92 million at its later-stage round in Jul 2025, the last priced event on record. It has raised $44 million across 1 recorded round; the latest was a $27.5 million early-stage round in Jan 2024.

PMV mark · valuation
$92.0M
Oct 2026
Priced at
its later-stage round
Jul 2025
Total raised
$44.0M
Last round
Early Stage VC
Jan 2024

Who backs Clarametyx Biosciences?

8 investors
InvestorType
JobsOhio VenturesVenture capital
Rev1 VenturesVenture capital
CincyTechVenture capital
CARB-XOther
Nationwide Children's HospitalOther
Kineticos Life Sciences Management—
National Institute on Deafness and Other Communication Disorders—
Ohio Innovation Fund—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Clarametyx Biosciences investors

8 investors are on record for Clarametyx Biosciences, including JobsOhio Ventures, Rev1 Ventures, CincyTech and CARB-X. The early-stage round in Jan 2024 drew 7 investors.

Free account
More of Clarametyx Biosciences with a free account
  • ·Watch Clarametyx Biosciences: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 8 firms already write checks for companies like Clarametyx Biosciences. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View